Cargando…
Antidepressant-induced reduction in betel-quid use in patients with depression: A pioneer clinical study
Betel-quid is commonly used around the world and is listed as a Group I carcinogen. Prior research has suggested a possible association between antidepressants and betel-quid use. We aimed to clarify the effects of antidepressant therapy in betel-quid chewers in the population of patients with depre...
Autores principales: | Hung, Chung-Chieh, Lee, Chien-Hung, Chung, Chia-Min, Nithiyanantham, Srinivasan, Lane, Hsien-Yuan, Ko, Ying-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946344/ https://www.ncbi.nlm.nih.gov/pubmed/31895834 http://dx.doi.org/10.1097/MD.0000000000018672 |
Ejemplares similares
-
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial
por: Hung, Chung-Chieh, et al.
Publicado: (2020) -
Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis
por: Zhuo, Chuanjun, et al.
Publicado: (2017) -
Association between depression and enterovirus infection: A nationwide population-based cohort study
por: Liao, Yin-To, et al.
Publicado: (2017) -
Genomic Alterations in Breast Cancer Patients in Betel Quid and Non Betel Quid Chewers
por: Kaushal, Mishi, et al.
Publicado: (2012) -
Betel-Quid Chewing, Heart Failure, and Premature Ventricular Contractions in Patients with Cardiopulmonary Symptoms
por: Huang, Tien-Chi, et al.
Publicado: (2020)